Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basic leucine zipper ATF-like transcription factor 2 (BATF2) is a protein-coding gene that functions as a transcription factor in the AP-1 family, exerting control over the differentiation of immune system cells, especially CD8+ thymic conventional dendritic cells following infection. BATF2 forms heterodimers with JUN family proteins to regulate gene expression by binding to specific DNA motifs. It suppresses CCN1 transcription, thereby inhibiting pathways that can lead to cell proliferation and oncogenic growth in certain cancers. It is implicated in the immune response, transcriptional regulation, and the etiology of some cancers and rare syndromes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic leucine zipper ATF-like transcription factor 2 (BATF2).